|
Real-time Estimate
Cboe BZX
12:26:31 2026-10-21 EDT
|
5-day change | 1st Jan Change | ||
| 0.9750 USD | +4.84% |
|
-3.00% | -53.55% |
| 08-20 | ABVC BioPharma, Inc. completed the Spin-Off of BioKey, Inc. | CI |
| 08-12 | ABVC BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABVC BIOPHARMA, INC. | Bio Therapeutic Drugs | +6.39% | -3.00% | -53.55% | -66.12% | -96.25% | 24.11M |  | | |
- Stock Market
- Stocks
- ABVC Stock
- Charts ABVC BioPharma, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
